Literature DB >> 8522069

Two stages of enteropathogenic Escherichia coli intestinal pathogenicity are up and down-regulated by the epithelial cell differentiation.

J M Gabastou1, S Kernéis, M F Bernet-Camard, A Barbat, M H Coconnier, J B Kaper, A L Servin.   

Abstract

Pathogens and eucaryotic cells are active partners during the process of pathogenicity. To gain access to enterocytes and to cross the epithelial membrane, many enterovirulent microorganisms interact with the brush border membrane-associated components as receptors. Recent reports provide evidence that intestinal cell differentiation plays a role in microbial pathogenesis. Human enteropathogenic Escherichia coli (EPEC) develop their pathogenicity upon infecting enterocytes. To determine if intestinal epithelial cell differentiation influences EPEC pathogenicity, we examined the infection of human intestinal epithelial cells by JPN 15 (pMAR7) [EAF+ eae+] EPEC strain as a function of the cell differentiation. The human embryonic intestinal INT407 cells, the human colonic T84 cells, the human undifferentiated HT-29 cells (HT-29 Std) and two enterocytic cell lines, HT-29 glc-/+ and Caco-2 cells, were used as cellular models. Cells were infected apically with the EPEC strain and the cell-association and cell-entry were examined by quantitative determination using metabolically radiolabeled bacteria, as well as by light, scanning and transmission electron microscopy. [EAF+ eae+] EPEC bacteria efficiently colonized the cultured human intestinal cells. Diffuse bacterial adhesion occurred to undifferentiated HT-29 Std and INT407 cells, whereas characteristic EPEC cell clusters were observed on fully differentiated enterocytic HT-29 glc-/+ cells and on colonic crypt T84 cells. As shown using the Caco-2 cell line, which spontaneously differentiates in culture, the formation of EPEC clusters increased as a function of the epithelial cell differentiation. In contrast, efficient cell-entry of [EAF+ eae+] EPEC bacteria occurred in recently differentiated Caco-2 cells and decreased when the cells were fully differentiated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 8522069      PMCID: PMC7130537          DOI: 10.1046/j.1432-0436.1995.5920127.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  59 in total

Review 1.  The interaction of bacteria with mammalian cells.

Authors:  S Falkow; R R Isberg; D A Portnoy
Journal:  Annu Rev Cell Biol       Date:  1992

2.  Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole.

Authors:  J Mounier; T Vasselon; R Hellio; M Lesourd; P J Sansonetti
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 3.  Disease processes in epithelia: the role of the actin cytoskeleton and altered surface membrane polarity.

Authors:  J Leiser; B A Molitoris
Journal:  Biochim Biophys Acta       Date:  1993-11-25

4.  Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers.

Authors:  C Canil; I Rosenshine; S Ruschkowski; M S Donnenberg; J B Kaper; B B Finlay
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

5.  Signal transduction in human epithelial cells infected with attaching and effacing Escherichia coli in vitro.

Authors:  M Dytoc; L Fedorko; P M Sherman
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

6.  Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation.

Authors:  D Darmoul; M Lacasa; L Baricault; D Marguet; C Sapin; P Trotot; A Barbat; G Trugnan
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

7.  Human cultured intestinal cells express attachment sites for uropathogenic Escherichia coli bearing adhesins of the Dr adhesin family.

Authors:  S Kernéis; J M Gabastou; M F Bernet-Camard; M H Coconnier; B J Nowicki; A L Servin
Journal:  FEMS Microbiol Lett       Date:  1994-06-01       Impact factor: 2.742

8.  How intestinal epithelial cell differentiation inhibits the cell-entry of Yersinia pseudotuberculosis in colon carcinoma Caco-2 cell line in culture.

Authors:  M H Coconnier; M F Bernet-Camard; A L Servin
Journal:  Differentiation       Date:  1994-11       Impact factor: 3.880

9.  Localized adherence by enteropathogenic Escherichia coli is an inducible phenotype associated with the expression of new outer membrane proteins.

Authors:  J Vuopio-Varkila; G K Schoolnik
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

10.  Biogenetic pathways of plasma membrane proteins in Caco-2, a human intestinal epithelial cell line.

Authors:  A Le Bivic; A Quaroni; B Nichols; E Rodriguez-Boulan
Journal:  J Cell Biol       Date:  1990-10       Impact factor: 10.539

View more
  12 in total

1.  Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules.

Authors:  J Guignot; M F Bernet-Camard; C Poüs; L Plançon; C Le Bouguenec; A L Servin
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Virulence of enteropathogenic Escherichia coli, a global pathogen.

Authors:  S C Clarke; R D Haigh; P P E Freestone; P H Williams
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

3.  Two atypical enteropathogenic Escherichia coli strains induce the production of secreted and membrane-bound mucins to benefit their own growth at the apical surface of human mucin-secreting intestinal HT29-MTX cells.

Authors:  Mônica A M Vieira; Tânia A T Gomes; Antonio J P Ferreira; Terezinha Knöbl; Alain L Servin; Vanessa Liévin-Le Moal
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

Review 4.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 5.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

6.  Localization of human intestinal defensin 5 in Paneth cell granules.

Authors:  E M Porter; L Liu; A Oren; P A Anton; T Ganz
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease.

Authors:  L M Higgins; G Frankel; G Douce; G Dougan; T T MacDonald
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

8.  Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells.

Authors:  M F Bernet-Camard; M H Coconnier; S Hudault; A L Servin
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

9.  Zipper-like internalization of Dr-positive Escherichia coli by epithelial cells is preceded by an adhesin-induced mobilization of raft-associated molecules in the initial step of adhesion.

Authors:  Imad Kansau; Cédric Berger; Maxime Hospital; Raymonde Amsellem; Valérie Nicolas; Alain L Servin; Marie-Françoise Bernet-Camard
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

10.  Invasiveness as a putative additional virulence mechanism of some atypical Enteropathogenic Escherichia coli strains with different uncommon intimin types.

Authors:  Denise Yamamoto; Rodrigo T Hernandes; Miguel Blanco; Lilo Greune; M Alexander Schmidt; Sylvia M Carneiro; Ghizlane Dahbi; Jesús E Blanco; Azucena Mora; Jorge Blanco; Tânia A T Gomes
Journal:  BMC Microbiol       Date:  2009-07-21       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.